The Cochrane Handbook's guidelines for meta-analysis were followed when interpreting the I 2 test (0-40% = may not be significant, 30-60% = may represent moderate heterogeneity, 50-90% = may represent substantial heterogeneity, and 75-100% = significant heterogeneity).
← all excerpts
Subcutaneous immunoglobulins (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIDP): A comprehensive systematic review of clinical studies and meta-analysis.
1
—
—